Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome von Thomsen, Maria, Skovlund, Eva, Sorbye, Halfdan, Bolstad, Nils, Nustad, Kjell Johannes, Glimelius, Bengt, Pfeiffer, Per, Kure, Elin H., Johansen, Julia S., Tveit, Kjell Magne, Christoffersen, Thoralf, Guren, Tormod Kyrre

Volltext

First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours von Robbrecht, Debbie, Jungels, Christiane, Sorensen, Morten Mau, Spanggaard, Iben, Eskens, Ferry, Fretland, Signe Ø, Guren, Tormod Kyrre, Aftimos, Philippe, Liberg, David, Svedman, Christer, Thorsson, Lars, Steeghs, Neeltje, Awada, Ahmad

Volltext

Transplant oncology: assessment of response and tolerance to systemic chemotherapy for metastatic colorectal cancer after liver transplantation – a retrospective study von Smedman, Tor Magnus, Guren, Tormod Kyrre, Line, Pål‐Dag, Dueland, Svein

Volltext

Clinicopathological factors associated with tumour‐specific mutation detection in plasma of patients with RAS‐mutated or BRAF‐mutated metastatic colorectal cancer von Hamfjord, Julian, Guren, Tormod Kyrre, Glimelius, Bengt, Sorbye, Halfdan, Pfeiffer, Per, Dajani, Olav, Lingjærde, Ole Christian, Tveit, Kjell Magne, Pallisgaard, Niels, Spindler, Karen‐Lise Garm, Kure, Elin H.

Volltext

Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer von Brunsvig, Paal F., Guren, Tormod Kyrre, Nyakas, Marta, Steinfeldt-Reisse, Claudius H., Rasch, Wenche, Kyte, Jon Amund, Juul, Hedvig Vidarsdotter, Aamdal, Steinar, Gaudernack, Gustav, Inderberg, Else Marit

Volltext

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer von Thomsen, Maria, Kersten, Christian, Sorbye, Halfdan, Skovlund, Eva, Glimelius, Bengt, Pfeiffer, Per, Johansen, Julia S, Kure, Elin H, Ikdahl, Tone, Tveit, Kjell Magne, Christoffersen, Thoralf, Guren, Tormod Kyrre

Volltext

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma-Five-Year Follow Up of a Phase I/IIa Trial von Aamdal, Elin, Inderberg, Else Marit, Ellingsen, Espen Basmo, Rasch, Wenche, Brunsvig, Paal Fredrik, Aamdal, Steinar, Heintz, Karen-Marie, Vodak, Daniel, Nakken, Sigve, Hovig, Eivind, Nyakas, Marta, Guren, Tormod Kyrre, Gaudernack, Gustav

Volltext

Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study von Marabelle, Aurelien, Cassier, Philippe Alexandre, Fakih, Marwan, Guren, Tormod Kyrre, Italiano, Antoine, Kao, Steven Chuan-Hao, Nielsen, Dorte, Ascierto, Paolo Antonio, Bariani, Giovanni M., Santoro, Armando, Shah, Manisha H., Asselah, Jamil, El-Khoueiry, Anthony B., Spencer, Kristen Renee, Takahashi, Shunji, Chatterjee, Arkendu, Jin, Fan, Norwood, Kevin, Delord, Jean-Pierre

Volltext

Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer von Mezheyeuski, Artur, Strell, Carina, Hrynchyk, Ina, Guren, Tormod Kyrre, Dragomir, Anca, Doroshenko, Tatyana, Pashkova, Oksana, Gorgun, Julia, Ruksha, Kseniya, Pfeiffer, Per, Kure, Elin H., Sorbye, Halfdan, Edler, David, Martling, Anna, Glimelius, Bengt, Östman, Arne, Portyanko, Anna

Volltext

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer von Mezheyeuski, Artur, Bradic Lindh, Maja, Guren, Tormod Kyrre, Dragomir, Anca, Pfeiffer, Per, Kure, Elin H, Ikdahl, Tone, Skovlund, Eva, Corvigno, Sara, Strell, Carina, Pietras, Kristian, Ponten, Fredrik, Mulder, Jan, Qvortrup, Camilla, Portyanko, Anna, Tveit, Kjell Magne, Glimelius, Bengt, Sorbye, Halfdan, Östman, Arne

Volltext

Combination therapies with HSP90 inhibitors against colorectal cancer von Kryeziu, Kushtrim, Bruun, Jarle, Guren, Tormod K., Sveen, Anita, Lothe, Ragnhild A.

Volltext

Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the... von Tabernero, Josep, Grothey, Axel, Van Cutsem, Eric, Yaeger, Rona, Wasan, Harpreet, Yoshino, Takayuki, Desai, Jayesh, Ciardiello, Fortunato, Loupakis, Fotios, Hong, Yong Sang, Steeghs, Neeltje, Guren, Tormod Kyrre, Arkenau, Hendrik-Tobias, Garcia-Alfonso, Pilar, Elez, Elena, Gollerkeri, Ashwin, Maharry, Kati, Christy-Bittel, Janna, Kopetz, Scott

Volltext

Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study von Hamfjord, Julian, Myklebust, Tor Åge, Larsen, Inger Kristin, Kure, Elin H, Glimelius, Bengt, Guren, Tormod K, Tveit, Kjell M, Guren, Marianne G

Volltext

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study von Guren, Tormod Kyrre, Thomsen, Maria, Kure, Elin H, Sorbye, Halfdan, Glimelius, Bengt, Pfeiffer, Per, Österlund, Pia, Sigurdsson, Fridbjörn, Lothe, Inger Marie Bowitz, Dalsgaard, Astrid Marie, Skovlund, Eva, Christoffersen, Thoralf, Tveit, Kjell Magne

Volltext

Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study von Hamfjord, Julian, Myklebust, Tor Åge, Larsen, Inger Kristin, Kure, Elin H., Glimelius, Bengt, Guren, Tormod Kyrre, Tveit, Magne Kjell, Guren, Marianne

Volltext

Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study von Yap, Timothy A, Nakagawa, Kazuhiko, Fujimoto, Nobukazu, Kuribayashi, Kozo, Guren, Tormod Kyrre, Calabrò, Luana, Shapira-Frommer, Ronnie, Gao, Bo, Kao, Steven, Matos, Ignacio, Planchard, David, Chatterjee, Arkendu, Jin, Fan, Norwood, Kevin, Kindler, Hedy L

Volltext

Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy von Smedman, Tor Magnus, Guren, Tormod Kyrre, Tveit, Kjell Magne, Thomsen, Maria, Andersen, Marit Helen, Line, Pål-Dag, Dueland, Svein

Volltext

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma von Nyakas, M., Aamdal, E., Jacobsen, K. D., Guren, T. K., Aamdal, S., Hagene, K. T., Brunsvig, P., Yndestad, A., Halvorsen, B., Tasken, K. A., Aukrust, P., Mælandsmo, G. M., Ueland, T.

Volltext

A phase I/IIa clinical trial investigating the therapeutic cancer vaccine UV1 in combination with ipilimumab in patients with malignant melanoma: Four-year survival update von Ellingsen, Espen Basmo, Aamdal, Elin, Inderberg, Else Marit, Rasch, Wenche, Brunsvig, Paal, Aamdal, Steinar, Hovig, Eivind, Nyakas, Marta, Guren, Tormod Kyrre, Gaudernack, Gustav

Volltext

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials von Ellingsen, Espen Basmo, Aamdal, Elin, Guren, Tormod, Lilleby, Wolfgang, Brunsvig, Paal F, Mangsbo, Sara M, Aamdal, Steinar, Hovig, Eivind, Mensali, Nadia, Gaudernack, Gustav, Inderberg, Else Marit

Volltext